MARKETS
Technology

Apimeds’ Subsidiary MindWave Signs 12-Month Software Development And Technology Services Agreement With Flash Sports & Media To Build And Operate FlashChain

Sep 29, 2026 · 08:33 AM ET· updated 51m ago

MindWave Innovations Inc. ("MindWave"), a wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc. (NYSE:APUS), has signed a 12-month software development and technology services agreement with New York-based

Share
Why It Matters

Apimeds' software company MindWave signed a deal to build technology for a sports company. When a company gets new customer contracts, it shows people want what they make.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.